Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC
Clinical trial NCT04858828 · UNKNOWN
Trial details
- NCT number
- NCT04858828
- Sponsor
- Zhou Chengzhi
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.